Literature DB >> 18618604

A rationale for the targeted treatment of oligometastases with radiotherapy.

Dhara M Macdermed1, Ralph R Weichselbaum, Joseph K Salama.   

Abstract

An oligometastatic state has been proposed wherein patients with metastases limited in number and location may benefit from local therapy directed at all known sites of metastases. We describe here the clinical and biological basis for the oligometastatic state. We present evidence for a potentially curative approach to patients with oligometastases using stereotactic body radiotherapy (SBRT) and we review the literature for SBRT directed at specific metastatic sites in the lungs, liver and multiple organs.

Entities:  

Mesh:

Year:  2008        PMID: 18618604     DOI: 10.1002/jso.21102

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  39 in total

1.  Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature.

Authors:  Concetta Elisa Onesti; Daniela Iacono; Silvia Angelini; Salvatore Lauro; Marco Mazzotta; Mario Alberto Occhipinti; Raffaele Giusti; Paolo Marchetti
Journal:  Transl Lung Cancer Res       Date:  2016-12

Review 2.  Thermal Ablation of Bone Metastases.

Authors:  Michael R Moynagh; A Nicholas Kurup; Matthew R Callstrom
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

3.  Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice.

Authors:  Magdalena Fundowicz; Marta Adamczyk; Anna Kołodziej-Dybaś
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-04

4.  Is there always a need for invasive treatment of limited liver metastases in renal cell cancer or other solid tumors?

Authors:  Frank Bruns; Hans Christiansen
Journal:  World J Urol       Date:  2014-06-01       Impact factor: 4.226

5.  Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver.

Authors:  Fumitaka Ishige; Wataru Takayama; Satoshi Chiba; Isamu Hoshino; Hidehito Arimitsu; Hiroo Yanagibashi; Yosuke Iwatate
Journal:  Int J Clin Oncol       Date:  2018-03-06       Impact factor: 3.402

Review 6.  Thoracolumbar corpectomy/spondylectomy for spinal metastasis: a pooled analysis comparing the outcome of seven different surgical approaches.

Authors:  Alexander Spiessberger; Varun Arvind; Basil Gruter; Samuel K Cho
Journal:  Eur Spine J       Date:  2019-10-22       Impact factor: 3.134

7.  Local consolidative therapy for oligometastatic non-small cell lung cancer.

Authors:  Pamela P Samson; Matthew B Spraker; Shahed N Badiyan; Gregory Vlacich; Clifford G Robinson; Aadel A Chaudhuri
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 8.  Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer.

Authors:  Tokujiro Yano; Tatsuro Okamoto; Seiichi Fukuyama; Yoshihiko Maehara
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  OXavidin for tissue targeting biotinylated therapeutics.

Authors:  Rita De Santis; Claudio Albertoni; Antonio Rosi; Barbara Leoni; Fiorella Petronzelli; Valeria D'Alessio; Eleonora Nucera; Giovanni Salvatori; Giovanni Paganelli; Antonio Verdoliva; Paolo Carminati; Carlo Antonio Nuzzolo
Journal:  J Biomed Biotechnol       Date:  2010-01-10

Review 10.  Stereotactic body radiotherapy treatment of extracranial metastases.

Authors:  Joseph K Salama; John P Kirkpatrick; Fang-Fang Yin
Journal:  Nat Rev Clin Oncol       Date:  2012-09-25       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.